Karyopharm Therapeutics
KPTI
KPTI
113 hedge funds and large institutions have $113M invested in Karyopharm Therapeutics in 2024 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
9% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 22
3% less funds holding
Funds holding: 117 → 113 (-4)
Holders
113
Holding in Top 10
–
Calls
$330K
Puts
$321K
Top Buyers
| 1 | +$7.57M | |
| 2 | +$2.77M | |
| 3 | +$1.01M | |
| 4 |
D.E. Shaw & Co
New York
|
+$522K |
| 5 |
State Street
Boston,
Massachusetts
|
+$350K |
Top Sellers
| 1 | -$2.11M | |
| 2 | -$1.6M | |
| 3 | -$1.57M | |
| 4 |
BlackRock
New York
|
-$942K |
| 5 |
TC
Tejara Capital
London,
United Kingdom
|
-$892K |